Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis
Authors:
- Pedro Santos MorenoPMPedro Santos Moreno
- Rodrigo García SalinasRSRodrigo García Salinas
- Carlo Vinicio Caballero UribeCUCarlo Vinicio Caballero Uribe
- María Lorena BranceMBMaría Lorena Brance
- Nicolas M Marín ZúcaroNZNicolas M Marín Zúcaro
- Dina Arrieta VegaDVDina Arrieta Vega
- Adriana BeltránABAdriana Beltrán
- Sonia CabreraSCSonia Cabrera
- Rosa Chacon DiazRDRosa Chacon Diaz
- Inés CorbachoICInés Corbacho
- Oscar Jair Felipe DiazODOscar Jair Felipe Diaz
- Rocio GamboaRGRocio Gamboa
- 13 November 2025
- journal article
- practice guideline
- Published by Elsevier in The Lancet Rheumatology
- Vol. 8 (1) , e53-e65
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic DrugsJAMA Network Open, 2023
- Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort studyRheumatology International, 2021
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis Care & Research, 2021
- Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled TrialArthritis & Rheumatology, 2020
- Efficacy and Safety of Long‐Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus MethotrexateArthritis Care & Research, 2019
- “Official View” on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus StatementsArthritis Care & Research, 2017
- Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF DrugJAMA, 2016
- Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort studyClinical Rheumatology, 2014
- Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab RegistryArthritis Care & Research, 2011
- Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeksArthritis & Rheumatism, 2006